IPSCCentury Therapeutics Inc. Common Stock

2.070USD-1.90%Mkt Cap: 374.83M $P/E:

Century Therapeutics, Inc., a biotechnology company, engages in the development of allogeneic cell therapies for the treatment of solid tumor, hematological malignancies, and autoimmune diseases. Its lead product candida…

Key Statistics

Company
Market Cap374.83M $
Enterprise Value284.73M $
Revenue (TTM)0 $
Gross Profit-78.93M $
Net Income (TTM)-9.58M $
Revenue/Share0.0000 USD
Last Price2.070 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees78
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-4.46
PEG
EV/EBITDA-2.99
EV/Revenue
P/SInfinity
P/B1.57
EPS (TTM)-0.89
EPS (Forward)-0.45
52W Range
0.435063% of range3.040
52W High3.040 USD
52W Low0.4350 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-8.78%
ROE-6.03%
ROA-4.28%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-103.88M $
CapEx (TTM)848.00K $
FCF Margin
FCF Yield-13.45%
Net Debt-81.05M $
Net Debt/EBITDA0.85
Balance Sheet
Debt/Equity0.27
Current Ratio8.28
Quick Ratio8.04
Book Value/Sh1.287 USD
Cash/Share0.6610 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.750 USD
Upside (mean)+129.5%
Target Range2.000 USD8.000 USD
$2.000+129.5% to mean$8.000
# Analysts4
Ownership
Shares Out.181.08M
Float100.88M
Insiders8.15%
Institutions87.40%
Short Interest
Short Ratio25.7d
Short % Float16.66%
Short % Out.16.53%
Shares Short29.82M
Short (prev mo.)23.46M
Technical
SMA 502.172 (-4.7%)
SMA 2001.862 (+11.2%)
Beta1.60
S&P 52W Chg18.16%
Avg Vol (30d)740.17K
Avg Vol (10d)451.78K
Technical Indicators
RSI (14)50.1
MACD-0.0484
MACD Signal-0.0643
MACD Hist.+0.0159
BB Upper2.187 USD
BB Middle2.024 USD
BB Lower1.861 USD
BB Width16.06%
ATR (14)0.1196 USD
Vol Ratio (20d)0.56x